Skip to main content
. Author manuscript; available in PMC: 2019 Mar 14.
Published in final edited form as: Diabetes Metab Res Rev. 2017 Aug 30;33(8):10.1002/dmrr.2922. doi: 10.1002/dmrr.2922

Table 3.

Logistic regression models for type 2 diabetes in relation to anti-PFDN2 antibodies

Model adjustments OR (95% CI) p value
Unadjusted model
 Anti-PFDN2 antibody 1.33 (1.15, 1.54) 0.0001
Adjusted model 1:
 Anti-PFDN2 antibody 1.30 (1.12, 1.50) 0.0006
Adjusted model 2:
 Anti-PFDN2 antibody 1.30 (1.12, 1.50) 0.002
 SAI heritage 1.33 (0.95, 1.87) 0.10
Adjusted model 3:
 Anti-PFDN2 antibody 1.27 (1.09, 1.49) 0.003
 SAI heritage 1.11 (0.77, 1.60) 0.58
 BMI 2.31 (1.93, 2.76) <0.0001
Adjusted model 4:
 Anti-PFDN2 antibody 1.27 (1.09, 1.49) 0.003
 SAI heritage 1.08 (0.75, 1.57) 0.68
 BMI 2.31 (1.93, 2.76) <0.0001
 Protective SNP haplotype (rs9268852) 0.61 (0.40, 0.93) 0.02

Abbreviations: BMI, body mass index; SAI, Southwest American Indian; SNP, single-nucleotide polymorphism

Models 1–4 are also adjusted for age and sex

Anti-PFDN2 antibody and BMI were standardized to a normal distribution with SD = 1; ORs are given for a one SD difference in antibody level

n =796 with complete data for all variables